Kurs
-5,05%
Kurs
-5,05%
Open
53,00
High
53,40
Low
50,80
Close
50,80
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
5,27 MNOK
Likviditet
5,27 MNOK
Rel. mcap
0,39%
Antal aktier
101 668
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2025-10-29 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-30 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | - | Kvartalsrapport 2025-Q1 |
| 2025-05-06 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2025-05-05 | - | Årsstämma |
| 2025-02-19 | - | Bokslutskommuniké 2024 |
| 2024-11-13 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-07 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-24 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2024-05-23 | - | Årsstämma |
| 2024-05-15 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-21 | - | Bokslutskommuniké 2023 |
| 2023-11-08 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-09 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-04 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2023-05-03 | - | Årsstämma |
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-02 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-10 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-29 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2022-04-28 | - | Årsstämma |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-11 | - | Kvartalsrapport 2021-Q2 |
| 2021-07-28 | - | Extra Bolagsstämma 2021 |
| 2021-05-21 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2021-05-20 | - | Årsstämma |
| 2021-05-19 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-03 | - | Bokslutskommuniké 2020 |
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-11 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2020-06-10 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-07 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-19 | - | Extra Bolagsstämma 2019 |
| 2019-05-14 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-08 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-08 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-23 | - | Kvartalsrapport 2018-Q1 |
| 2018-05-11 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2018-05-09 | - | Årsstämma |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-11-08 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-23 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-23 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-28 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2017-04-27 | - | Årsstämma |
| 2017-02-15 | - | Bokslutskommuniké 2016 |
| 2016-11-15 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-23 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-29 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2016-04-28 | - | Årsstämma |
| 2016-02-11 | - | Bokslutskommuniké 2015 |
| 2015-10-29 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | - | Kvartalsrapport 2015-Q1 |
| 2015-05-02 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2015-04-30 | - | Årsstämma |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-11-06 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-26 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-28 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2014-05-27 | - | Årsstämma |
| 2014-05-07 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-22 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-23 | - | X-dag ordinarie utdelning |
| 2013-05-22 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-28 | - | Bokslutskommuniké 2012 |
| 2012-10-26 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-24 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | - | Årsstämma |
| 2012-04-26 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-16 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-18 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-27 | - | Årsstämma |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-10-27 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-19 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-28 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-26 | - | X-dag bonusutdelning |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2023-11-20 17:50:30
Press Release - Oslo, Norway, November 20, 2023: Photocure ASA (OSE: PHO), The
Bladder Cancer Company, announces its participation in four investor conferences
focusing on the healthcare sector in Q4 2023:
The SEB Healthcare Seminar will take place in Stockholm, November 21-23, 2023.
David Moskowitz, Photocure's Vice President Investor Relations will present a
corporate overview on November 22 at 10:40am CET.
The 35[th] Annual Piper Sandler Healthcare Conference will be held in New York
City, November 28-30, 2023. Dan Schneider, Photocure's President and CEO will
present on November 28 at 9:50am ET. A webcast of the presentation will be
available at: Photocure ASA (PHO NO) - 1644046
(webcasts.com) (https://pgi.webcasts.com/starthere.jsp?ei=1644046&tp_key=04b1c8d
9
a7)
The 2023 Nordic American Healthcare Conference is scheduled to be held December
6-7 in New York City. Dan Schneider will present a corporate overview on
December 6 at 2:30pm ET.
The 14[th] Annual DNB Nordic Healthcare Conference will be held in Oslo on
December 14, 2023. Photocure's President and CEO Dan Schneider will present a
corporate overview at 3:35pm CET.
For further information, please contact:
Dan Schneider
President and CEO
Photocure ASA
Email: ds@photocure.com
Erik Dahl
CFO
Photocure ASA
Tel: +4745055000
Email: ed@photocure.com
David Moskowitz
Vice President, Investor Relations
Photocure ASA
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com